Respiratory Syncytial Virus–Related Hospitalizations Among Infants Receiving Nirsevimab
Key Points Question Was nirsevimab clinically effective against respiratory syncytial virus (RSV)–related emergency department (ED) visits, inpatient hospitalizations, and intensive care unit (ICU) admissions in Ontario and Quebec, Canada, during the 2024-2025 RSV season? Findings In this test-negative case-control stu...